<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-155518" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Lymphocytic Esophagitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aleem</surname>
            <given-names>Abdul</given-names>
          </name>
          <aff>Lehigh Valley Health Network, Allentown, USA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tian</surname>
            <given-names>Chenlu</given-names>
          </name>
          <aff>UT Southwestern Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abdul Aleem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Chenlu Tian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-155518.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Initially described by Rubio et al in 2006, lymphocytic esophagitis (LE) is a rare subtype of chronic esophagitis with a unique histologic phenotype characterized by increased peripapillary intraepithelial lymphocytes in the absence or minimal presence of intraepithelial granulocytes.<xref ref-type="bibr" rid="article-155518.r1">[1]</xref>&#x000a0;The rising incidence of LE is likely secondary to raising awareness of this condition among clinicians and pathologists and the increased frequency of performing esophageal biopsies in the clinical investigation of esophageal dysphagia. The significant efforts of researchers worldwide have led to better characterization of LE's clinical, endoscopic, and histological features.&#x000a0;</p>
        <p>The clinical presentation of LE is variable and may include dysphagia, dyspepsia, nausea,&#x000a0;or chest pain. Frequently diagnosed in older women, LE is associated with a history of tobacco use,&#x000a0;gastroesophageal reflux disease (GERD), and achalasia.</p>
        <p>This activity reviews the etiology, epidemiology, clinical characteristics, diagnosis, management, and complications of this rare but emerging subtype of&#x000a0;chronic esophagitis. It highlights the role of the interprofessional healthcare team in caring for patients with this gastrointestinal disorder.</p>
      </sec>
      <sec id="article-155518.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Lymphocytic esophagitis is a rare subtype of chronic esophagitis, and the etiology is unknown. It is unclear whether&#x000a0;LE is a unique primary inflammatory esophageal disease or merely a marker of an underlying esophageal or systemic immune-mediated disease process.<xref ref-type="bibr" rid="article-155518.r2">[2]</xref>&#x000a0;However, with predominant clinical features such as persistent dysphagia,&#x000a0;the suggestion of&#x000a0;esophageal strictures documented during endoscopic evaluation, and histopathologic evidence consistent with lymphocytosis, LE is likely a chronic inflammatory disorder of the esophagus.<xref ref-type="bibr" rid="article-155518.r3">[3]</xref>&#x000a0;Extensive prospective studies are required to evaluate the natural history of LE.</p>
      </sec>
      <sec id="article-155518.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Knowledge of the natural history of&#x000a0;LE is limited, given the relatively few studies of the condition. The incidence of&#x000a0;LE has been reported to be 0.1% of total esophageal biopsies based on the results of a large pilot study in the United States of more than 40,000 patients.<xref ref-type="bibr" rid="article-155518.r4">[4]</xref>&#x000a0;Worldwide demographic data on the incidence of&#x000a0;LE is limited.&#x000a0;</p>
        <p>The signs and symptoms of&#x000a0;LE mimic those of eosinophilic esophagitis; both are definitively diagnosed via endoscopic esophageal biopsy. Evaluations for eosinophilic esophagitis have been steadily increasing, and this increased number of endoscopic esophageal biopsies is presumed to be the reason behind the increasing incidence of LE diagnoses.</p>
        <p>Initial studies of LE reported its association with immunologic conditions such as rheumatologic disorders, common variable immunodeficiency, and Crohn disease, especially in pediatric patients.<xref ref-type="bibr" rid="article-155518.r1">[1]</xref><xref ref-type="bibr" rid="article-155518.r5">[5]</xref><xref ref-type="bibr" rid="article-155518.r6">[6]</xref><xref ref-type="bibr" rid="article-155518.r7">[7]</xref>&#x000a0;However, multiple subsequent studies evaluating the potential risk factors for&#x000a0;developing LE have reported that the disorder is more likely&#x000a0;in women in their sixth decade and&#x000a0;is significantly associated with underlying GERD, primary motility disorders such as achalasia, a history of tobacco use, certain allergies, hypothyroidism and the use of aspirin or statin medications.<xref ref-type="bibr" rid="article-155518.r8">[8]</xref><xref ref-type="bibr" rid="article-155518.r9">[9]</xref><xref ref-type="bibr" rid="article-155518.r10">[10]</xref><xref ref-type="bibr" rid="article-155518.r11">[11]</xref><xref ref-type="bibr" rid="article-155518.r12">[12]</xref></p>
      </sec>
      <sec id="article-155518.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathogenesis of&#x000a0;LE&#x000a0;is not well understood. The development of&#x000a0;LE has been hypothesized to occur secondary to either a hypersensitivity reaction to an ingestant or an underlying autoimmune phenomenon.<xref ref-type="bibr" rid="article-155518.r13">[13]</xref><xref ref-type="bibr" rid="article-155518.r14">[14]</xref><xref ref-type="bibr" rid="article-155518.r15">[15]</xref>&#x000a0;Authors of a case series of 42 patients with LE refuted hypotheses suggesting an association of&#x000a0;LE with any medication, concurrent disease, or allergies.<xref ref-type="bibr" rid="article-155518.r14">[14]</xref></p>
        <p>The histological pattern reported by Rubio et al in their original study reported increased expression of CD3, CD4, and CD8 proteins by esophageal intraepithelial lymphocytes.<xref ref-type="bibr" rid="article-155518.r1">[1]</xref></p>
        <p>A 36-month observational study by Xue et al of esophageal biopsies&#x000a0;from 45 patients with&#x000a0;LE&#x000a0;reported that increased expression of CD4 by intraepithelial lymphocytes had a significantly higher prevalence of primary motility abnormalities compared to patients with CD8 predominant LE.<xref ref-type="bibr" rid="article-155518.r16">[16]</xref></p>
        <p>Another study by Putra et al reported a strong association&#x000a0;between&#x000a0;LE&#x000a0;and non-achalasia primary esophageal motility disorders with an odds ratio of 7.72 (95% CI, 2.26-27.9).<xref ref-type="bibr" rid="article-155518.r9">[9]</xref></p>
      </sec>
      <sec id="article-155518.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Lymphocytic esophagitis is a histologic diagnosis. However, there is no consensus on the minimal number of intraepithelial lymphocytes required to diagnose LE. The 3 histologic findings widely recognized&#x000a0;as characteristic of&#x000a0;LE include&#x000a0;peripapillary lymphocytosis, marked spongiosis or intercellular edema, and the absence or minimal presence of intraepithelial granulocytes such as neutrophils or eosinophils in the absence of any apparent infectious etiology.<xref ref-type="bibr" rid="article-155518.r17">[17]</xref></p>
        <p>Spongiosis, found in many forms of esophagitis, has been noted as directly proportional to the degree of lymphocytosis.<xref ref-type="bibr" rid="article-155518.r3">[3]</xref><xref ref-type="bibr" rid="article-155518.r18">[18]</xref></p>
      </sec>
      <sec id="article-155518.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In contrast to eosinophilic esophagitis, usually diagnosed in young adult men, LE is predominantly seen in women in the sixth decade of life. The common presenting symptoms of LE include dysphagia, heartburn, or chest pain; nonspecific abdominal pain and nausea with or without vomiting have also been reported.<xref ref-type="bibr" rid="article-155518.r3">[3]</xref><xref ref-type="bibr" rid="article-155518.r10">[10]</xref>&#x000a0;A meta-analysis from 2019 identified that most patients with LE were women presenting with dysphagia.<xref ref-type="bibr" rid="article-155518.r12">[12]</xref></p>
        <p>A study of more than 100 patients with a histologic diagnosis of LE concluded that while most patients presented with clinical symptoms similar to eosinophilic esophagitis, they lacked the characteristic endoscopic features of that disease, including distinctive rings and furrows.<xref ref-type="bibr" rid="article-155518.r4">[4]</xref></p>
        <p>A single-center retrospective study evaluating the prevalence of eosinophilic esophagitis and&#x000a0;LE in adults presenting with esophageal food bolus impaction demonstrated that 17% of the total 228 participating patients had features of both eosinophilic esophagitis and LE and 9% of patients had evidence of only LE, implicating food bolus impaction as the presenting feature of LE.<xref ref-type="bibr" rid="article-155518.r19">[19]</xref></p>
      </sec>
      <sec id="article-155518.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>An endoscopic esophageal biopsy is required to obtain the necessary tissue sample to diagnose LE histologically. However, unlike eosinophilic esophagitis, there are no guidelines&#x000a0;for a formal biopsy protocol when diagnosing LE.</p>
        <p>
<bold>Esophagogastroduodenoscopy&#x000a0;</bold>
</p>
        <p>The gross endoscopic features of LE vary widely. They may range from a normal-appearing esophagus to findings of esophageal strictures&#x000a0;or rings, linear furrows, erosive esophagitis, esophageal edema, or white plaques.<xref ref-type="bibr" rid="article-155518.r3">[3]</xref><xref ref-type="bibr" rid="article-155518.r10">[10]</xref>&#x000a0;With conventional endoscopy evaluation, as many as 23% to 55% of patients with histologic LE will have normal esophageal mucosa.<xref ref-type="bibr" rid="article-155518.r1">[1]</xref><xref ref-type="bibr" rid="article-155518.r4">[4]</xref></p>
        <p>Using narrow-band imaging magnifying endoscopy (NBI-ME), Tanaka et al aimed to&#x000a0;distinguish the gross endoscopic features of LE, GERD, and eosinophilic esophagitis. Studied features included the presence of invisible submucosal vessels, beige-colored esophageal mucosa, and increased numbers of dot-shaped congested intrapapillary loops. Only 82% of patients in the&#x000a0;LE cohort demonstrated all three features compared to 100% of patients in the eosinophilic esophagitis cohort.<xref ref-type="bibr" rid="article-155518.r20">[20]</xref></p>
        <p>There is no consensus on the minimal number of lymphocytes per high-power field&#x000a0;required to diagnose LE. However, esophageal biopsies demonstrating a histological pattern of more than 20 intraepithelial lymphocytes per high-power field,&#x000a0;few or absent granulocytes, and mucosal injury such as spongiosis have been accepted widely as diagnostic criteria.<xref ref-type="bibr" rid="article-155518.r5">[5]</xref></p>
        <p>
<bold>Radiographic Studies</bold>
</p>
        <p>Radiographic studies such as barium esophagram&#x000a0;can evaluate for structural causes of dysphagia, including moderate-to-severe esophagitis, esophageal strictures, hiatal hernia, and neoplasms. However, the role of radiographic studies&#x000a0;in diagnosing&#x000a0;LE is limited.</p>
        <p>
<bold>Other Studies</bold>
</p>
        <p>Patients with a confirmed histologic diagnosis of&#x000a0;LE without gross endoscopic structural abnormalities should be evaluated for underlying achalasia and non-achalasia primary esophageal motility disorders using high-resolution esophageal manometry (HREM), given the significant association between motility disorders and LE. These patients also require laboratory evaluation for rheumatological and autoimmune diseases if the medical history and physical examination support such a diagnosis.</p>
      </sec>
      <sec id="article-155518.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of&#x000a0;LE&#x000a0;remains ill-defined due to a lack of clinical guidelines. Current management strategies for LE mimic those of eosinophilic esophagitis&#x000a0;due to the clinical and endoscopic similarities of the two disease processes. However, LE is more likely to respond to medical therapy than eosinophilic esophagitis.<xref ref-type="bibr" rid="article-155518.r8">[8]</xref> Unlike eosinophilic esophagitis, the role of systemic steroids and biologic therapy has not been studied in patients with LE.</p>
        <p>
<bold>Lifestyle Modifications</bold>
</p>
        <p>Patients with LE who use tobacco should receive education and support regarding tobacco cessation.</p>
        <p>
<bold>Medical Management</bold>
</p>
        <p>Medical management of LE comprises high-dose proton pump inhibitor (PPI) therapy twice daily for 12 weeks. Changes in symptomatology or endoscopic findings should be assessed after this course of therapy. If no clinical or histologic improvement is achieved with high-dose PPI therapy, topical steroids such as&#x000a0;budesonide&#x000a0;1 mg twice daily are recommended. Most patients report improved&#x000a0;symptoms with the initiation of PPI therapy. However, it is unclear if the symptomatic improvement is secondary to the treatment of underlying GERD.<xref ref-type="bibr" rid="article-155518.r17">[17]</xref>&#x000a0;In a small study of 22 patients with a confirmed diagnosis of LE, histological remission was achieved in 40% of patients with a course of high-dose PPI therapy; given the small sample size, further studies are needed.<xref ref-type="bibr" rid="article-155518.r17">[17]</xref><xref ref-type="bibr" rid="article-155518.r14">[14]</xref></p>
        <p><bold>Endoscopic Therapeutic Interventions</bold>&#x000a0;</p>
        <p>Serial endoscopic dilatation is advised for patients with LE with persistent symptomatic esophageal strictures or rings despite medical therapy.<xref ref-type="bibr" rid="article-155518.r21">[21]</xref></p>
      </sec>
      <sec id="article-155518.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of LE includes but is not limited to the following disease processes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gastroesophageal reflux disease</p>
          </list-item>
          <list-item>
            <p>Erosive esophagitis</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Candida</italic> esophagitis</p>
          </list-item>
          <list-item>
            <p>Eosinophilic esophagitis&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Esophageal lichen planus</p>
          </list-item>
          <list-item>
            <p>Achalasia&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Non-achalasia esophageal motility disorder</p>
          </list-item>
          <list-item>
            <p>Peptic stricture</p>
          </list-item>
          <list-item>
            <p>Esophageal neoplasm</p>
          </list-item>
          <list-item>
            <p>IgG4-related esophagitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-155518.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Data&#x000a0;delineating the natural history of&#x000a0;LE are scarce. However, based on the described responses to conventional high-dose PPI medical therapy, the disease runs a chronic but benign course.<xref ref-type="bibr" rid="article-155518.r2">[2]</xref>&#x000a0;A retrospective study by Cohen et al&#x000a0;of 81 patients with LE&#x000a0;indicated that most patients&#x000a0;report a good quality of life.<xref ref-type="bibr" rid="article-155518.r2">[2]</xref> Early diagnosis of LE and monitoring for complications such as esophageal strictures are crucial to prevent long-term morbidity.</p>
      </sec>
      <sec id="article-155518.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The complications of LE include esophageal strictures, webs, and perforation.</p>
      </sec>
      <sec id="article-155518.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Modifiable risk factors for the development of LE include tobacco use and underlying GERD. Patients with LE who use tobacco products should receive education and support regarding tobacco cessation.&#x000a0;</p>
        <p>Medical management of LE should include high-dose PPI therapy; this regimen should also address any symptoms caused by underlying GERD. Additionally, patients should be educated on lifestyle modifications to reduce GERD. These modifications may include avoiding foods that trigger reflux symptoms, waiting three hours after eating before reclining, avoiding late-night snacks, and elevating the head of the bed during sleep.</p>
        <p>Patients should be educated that while LE is a chronic disease, it is benign and not life-threatening. Patients should be encouraged to adhere to medical management and lifestyle modification strategies, monitor their symptoms, and attend all follow-up appointments, including those for repeat endoscopic evaluation and possible biopsy.</p>
      </sec>
      <sec id="article-155518.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Most patients with symptoms of dysphagia and food impaction will present to their primary care practitioner for evaluation and management. However, given the limited understanding of LE and its variable clinical presentation, primary care practitioners should engage the consultative services of a gastroenterologist if gastrointestinal symptoms do not completely resolve in response to lifestyle modifications and routine medical management of GERD. Close collaboration between gastroenterologists and pathologists is required to arrive at a diagnosis of LE. Clinical nursing staff plays a critical role in ensuring patients understand the necessary lifestyle modifications to manage LE and understand the necessity for committing to all follow-up appointments.&#x000a0;</p>
        <p>More extensive prospective studies evaluating the natural history of LE with long-term follow-up are needed to understand the condition. Further research could help clinicians tailor care to&#x000a0;improve outcomes with this specific disease process.</p>
      </sec>
      <sec id="article-155518.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=155518&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=155518">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/lymphocytic-esophagitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=155518">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/155518/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=155518">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-155518.s15">
        <title>References</title>
        <ref id="article-155518.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rubio</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Sj&#x000f6;dahl</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lagergren</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis: a histologic subset of chronic esophagitis.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>125</volume>
            <issue>3</issue>
            <fpage>432</fpage>
            <page-range>432-7</page-range>
            <pub-id pub-id-type="pmid">16613348</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saxena</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Waljee</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Piraka</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Purdy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Appelman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Elmunzer</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Singal</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis: a diagnosis of increasing frequency.</article-title>
            <source>J Clin Gastroenterol</source>
            <year>2012</year>
            <season>Nov-Dec</season>
            <volume>46</volume>
            <issue>10</issue>
            <fpage>828</fpage>
            <page-range>828-32</page-range>
            <pub-id pub-id-type="pmid">22751335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pittman</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic Esophagitis: Current Understanding and Controversy.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2022</year>
            <month>Jan</month>
            <day>01</day>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>e55</fpage>
            <page-range>e55-e63</page-range>
            <pub-id pub-id-type="pmid">33481383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haque</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Genta</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition.</article-title>
            <source>Gut</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>61</volume>
            <issue>8</issue>
            <fpage>1108</fpage>
            <page-range>1108-14</page-range>
            <pub-id pub-id-type="pmid">22157333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouphael</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>IO</given-names>
              </name>
              <name>
                <surname>Thota</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis: Still an enigma a decade later.</article-title>
            <source>World J Gastroenterol</source>
            <year>2017</year>
            <month>Feb</month>
            <day>14</day>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>949</fpage>
            <page-range>949-956</page-range>
            <pub-id pub-id-type="pmid">28246468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sutton</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Heintz</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis in children.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>8</issue>
            <fpage>1324</fpage>
            <page-range>1324-8</page-range>
            <pub-id pub-id-type="pmid">24983984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ebach</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Vanderheyden</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Ellison</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>CS</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn's disease.</article-title>
            <source>Inflamm Bowel Dis</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-9</page-range>
            <pub-id pub-id-type="pmid">20848529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaver</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Ghoz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Malviya</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Brahmbhatt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Lacy</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>DeVault</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Krishna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes.</article-title>
            <source>Dig Dis Sci</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>66</volume>
            <issue>11</issue>
            <fpage>3976</fpage>
            <page-range>3976-3984</page-range>
            <pub-id pub-id-type="pmid">33216240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Putra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gabbard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brickley</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Lacy</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Rothstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lisovsky</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic Esophagitis in Nonachalasia Primary Esophageal Motility Disorders: Improved Criteria, Prevalence, Strength of Association, and Natural History.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>12</issue>
            <fpage>1679</fpage>
            <page-range>1679-1685</page-range>
            <pub-id pub-id-type="pmid">27526295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasricha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Speck</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Woosley</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Dellon</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia.</article-title>
            <source>Dig Dis Sci</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>61</volume>
            <issue>10</issue>
            <fpage>2935</fpage>
            <page-range>2935-2941</page-range>
            <pub-id pub-id-type="pmid">27343035</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muller</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Xiao</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Putra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rothstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McCourt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Konnikova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lisovsky</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic Esophagitis With Predominance of CD4 T Cells and Expansion of Th1 Cells Is Associated With Achalasia.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2021</year>
            <month>Jul</month>
            <day>06</day>
            <volume>156</volume>
            <issue>2</issue>
            <fpage>278</fpage>
            <page-range>278-287</page-range>
            <pub-id pub-id-type="pmid">33609026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habbal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scaffidi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rumman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ramaj</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Al-Mazroui</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abunassar</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Jeyalingam</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shetty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kandel</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Streutker</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Clinical, endoscopic, and histologic characteristics of lymphocytic esophagitis: a systematic review.</article-title>
            <source>Esophagus</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-132</page-range>
            <pub-id pub-id-type="pmid">30370453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vangimalla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Thota</surname>
                <given-names>PN</given-names>
              </name>
            </person-group>
            <article-title>Image of the Month: Lymphocytic Esophagitis in Common Variable Immune Deficiency.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>170</fpage>
            <pub-id pub-id-type="pmid">26882931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Purdy</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Appelman</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Golembeski</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>508</fpage>
            <page-range>508-13</page-range>
            <pub-id pub-id-type="pmid">18794041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasirye</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Resnick</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis presenting as chronic dysphagia.</article-title>
            <source>Clin Med Res</source>
            <year>2012</year>
            <month>May</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>83</fpage>
            <page-range>83-4</page-range>
            <pub-id pub-id-type="pmid">22031480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Suriawinata</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Gabbard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rothstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lacy</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lisovsky</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic Esophagitis With CD4 T-cell-predominant Intraepithelial Lymphocytes and Primary Esophageal Motility Abnormalities: A Potential Novel Clinicopathologic Entity.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>11</issue>
            <fpage>1558</fpage>
            <page-range>1558-67</page-range>
            <pub-id pub-id-type="pmid">26379147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Islam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lampe</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis: An Australian (Queensland) case series of a newly recognized mimic of eosinophilic esophagitis.</article-title>
            <source>JGH Open</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>400</fpage>
            <page-range>400-404</page-range>
            <pub-id pub-id-type="pmid">31633045</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pittman</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hissong</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>PO</given-names>
              </name>
              <name>
                <surname>Yantiss</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Lymphocyte-predominant Esophagitis: A Distinct and Likely Immune-mediated Disorder Encompassing Lymphocytic and Lichenoid Esophagitis.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>198</fpage>
            <page-range>198-205</page-range>
            <pub-id pub-id-type="pmid">31651525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Truskaite</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dlugosz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Eosinophilic Esophagitis and Lymphocytic Esophagitis in Adults with Esophageal Food Bolus Impaction.</article-title>
            <source>Gastroenterol Res Pract</source>
            <year>2016</year>
            <volume>2016</volume>
            <fpage>9303858</fpage>
            <pub-id pub-id-type="pmid">27547221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rubio</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Dlugosz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Truskaite</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Befrits</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lindberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>PT</given-names>
              </name>
            </person-group>
            <article-title>Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>659</fpage>
            <page-range>659-64</page-range>
            <pub-id pub-id-type="pmid">23827349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-155518.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jideh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Keegan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Weltman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Lymphocytic esophagitis: Report of three cases and review of the literature.</article-title>
            <source>World J Clin Cases</source>
            <year>2016</year>
            <month>Dec</month>
            <day>16</day>
            <volume>4</volume>
            <issue>12</issue>
            <fpage>413</fpage>
            <page-range>413-418</page-range>
            <pub-id pub-id-type="pmid">28035315</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
